p53 over‐expression is an early event in the development of human squamous‐cell carcinoma of the larynx: Genetic and prognostic implications

International Journal of Cancer

Volumn 52, Issue 2, 1992, Pages 178-182

  Dolcetti, Riccardo ^a   Doglioni, Claudio ^b   Maestro, Roberta ^a   Gasparotto, Daniela ^a   Barzan, Luigi ^c   Pastore, Antonio ^d   Romanelli, Massimiliano ^e   Boiocchi, Mauro ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Division of Pathology   (Italy)

^c Ospedale Civile di Brescia   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e Ospedale Civile di Pordenone ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; PROGNOSIS; PROTEIN P53; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T;

EID: 0026793723     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910520204     Document Type: Article

References (22)

1. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia
2. Intraepithelial carcinoma (cancer in situ) of the larynx
3. Suppression of human colorectal carcinoma cell growth by wild‐Type p53
4. Isolation of human p53‐Specific monoclonal antibodies and their use in the studies of human p53 expression
5. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
6. Concomitant carcinoma in situ and invasive carcinoma of the larynx
7. Wild‐Type p53 can inhibit oncogene‐Mediated focus formation
8. p53 in chronic myelogenous leukemia in acute phase
9. The p53 proto‐Oncogene can act as a suppressor of transformation
10. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia
11. Different tumor‐Derived p53 mutants exhibit distinct biological activities
12. Increased expression of mutant forms of p53 oncogene in primary lung cancer
13. The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses
14. The p53 tumour‐Suppressor gene
15. High frequency of p53 alterations associated with protein over‐Expression in human squamous‐Cell carcinoma of the larynx
16. Carcinoma in situ of the larynx: a 20‐Year study of the results of its management
17. p53 mutations in colorectal cancer
18. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression
19. Structural aspects of the p53 protein in relation to gene evolution
20. Expression of p53 protein in infiltrating and in situ breast carcinomas
21. Reconstitution of p53 expression in a non‐Producer Ab‐MuLV‐Transformed cell line by transfection of a functional p53 gene